Clinical Trial Update: Phase II Trial of Neoadjuvant Temozolomide in Melanoma Patients With Palpable Stage III or IV Disease Undergoing Complete Surgical Resection [Phase 2]

View source ↗

Summary

Phase II trial evaluating neoadjuvant temozolomide in patients with palpable Stage III/IV melanoma undergoing complete surgical resection; results were posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Temozolomide (Temozolomide)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Melanoma, Skin Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-02-01